Bleeding in portal hypertension is serious and often killing complication in patients with liver cirrhosis. This paper deals with actual options of primary and secondary pharmacological prevention of bleeding from esophageal and gastric varices and from portal gastropathy, but also pharmacological approach to treatment of such a bleeding in progress.